Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
other: extrapolation from results obtained by the oral route
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Extrapolation based on available guidelines on route-to-route extrapolation of toxicity data when assessing health risks of chemicals.

Data source

Reference
Reference Type:
other: extrapolation
Title:
Unnamed
Year:
2011

Materials and methods

Principles of method if other than guideline:
Extrapolation based on available guidelines on route-to-route extrapolation of toxicity data when assessing health risks of chemicals.

Test material

Constituent 1
Chemical structure
Reference substance name:
Violet sodium polysulfide aluminosilicate with a SOD-type framework structure
EC Number:
701-186-2
Molecular formula:
|Na+6-x+y+z (S2•-)y (S3•-)z (S4)t|[Al6-x Si6+x O24] – SOD Where: 6 ≤ 6-x+ y+z ≤ 8 0 ≤ x ≤ 1.2 0 < y+z +t ≤ 2 t > 0 SOD = Sodalite framework structure
IUPAC Name:
Violet sodium polysulfide aluminosilicate with a SOD-type framework structure
Test material form:
solid
Details on test material:
- Name of test material: Ultramarine Violet (C.I. 77007 P igment Violet 15), Sodium Aluminosilicate Violet
- Molecular formula: |Na+6-x+y+z (S2•-)y (S3•-)z (S4)t|[Al6-x Si6+x O24] – SOD
Where:
6 ≤ 6-x+ y+z ≤ 8
0 ≤ x ≤ 1.2
0 < y+z +t ≤ 2
t > 0
SOD = Sodalite framework structure

- Molecular weight: 918 -1025

Results and discussion

Effect levels
Key result
Dose descriptor:
LC50
Effect level:
> 50 mg/L air

Any other information on results incl. tables

Based on available guidelines on route-to-route extrapolation of toxicity data when assessing health risks of chemicals, an extrapolation based on the acute oral toxicity data is calculated for the inhalation route.

From the available data on two acute oral toxicity studies, it is concluded that the oral LD50 for the substance is greater than 2000 mg/kg bw (study 1: no mortality was observed) and greater from 10000 mg/kg bw (study 2: mortality was observed). As recommended in the corresponding guidelines, where data from the oral route is being used as the starting point, if no data are available on oral bioavailability, it is appropriate to assume that 100% of an orally administered dose is systemically available. Since no data is available on inhalation absorption, the most precautionary default would be to assume 100% absorption by this route.

Based on this acute oral toxicity data, an oral NOAEL may be identified as greater than 10000 mg/kg bw. This NOAEL can be modified into an inhalation NOAEL using a route-to-route extrapolation based on the assumptions stated above. Taking into account an exposure of 4 hours for the acute inhalation toxicity study, the value of the oral LD50 is divided by the default physiological parameter under the allometric scaling principle which is approximately 0.2 m3/kg bw for rats. This extrapolation leads to a value of 10 mg/l (study 1) and 50 mg/l (study 2). Therefore, the 4 -h LC50 would be greater than 10 -50 mg/l.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
Based on the assumptions for the extrapolation from the acute oral toxicity data, the 4 -h LC50 would be greater than 10-50 mg/l.
Executive summary:

From the available data on two acute oral toxicity studies, it is concluded that the oral LD50 for the substance is greater than 2000 mg/kg bw (study 1: no mortality was observed) and greater from 10000 mg/kg bw (study 2: mortality was observed). As recommended in the corresponding guidelines, where data from the oral route is being used as the starting point, if no data are available on oral bioavailability, it is appropriate to assume that 100% of an orally administered dose is systemically available. Since no data is available on inhalation absorption, the most precautionary default would be to assume 100% absorption by this route.

Based on this acute oral toxicity data, an oral NOAEL may be identified as greater than 10000 mg/kg bw. This NOAEL can be modified into an inhalation NOAEL using a route-to-route extrapolation based on the assumptions stated above. Taking into account an exposure of 4 hours for the acute inhalation toxicity study, the value of the oral LD50 is divided by the default physiological parameter under the allometric scaling principle which is approximately 0.2 m3/kg bw for rats. This extrapolation leads to a value of 10 mg/l (study 1) and 50 mg/l (study 2). Therefore, the 4 -h LC50 would be greater than 10 -50 mg/l.